injury, for which there is currently no specific treatment. SERVICE: For further information , please contact Professor Dr. Dr. Thomas Thum, thum.thomas@mh-hannover.de , telephone (0511) 532-9174.

for the use of MYGDF as a new drug for heart failure. SERVICE: For further information , please contact Professor Dr. Kai Wollert, wollert.kai@mh-hannover.de , telephone (0511) 532-4055. The original paper

is well prepared for the future in terms of logistics. SERVICE: For further information , please contact Andreas Kohlhase, kohlhase.andreas@mh-hannover.de , telephone (0511) 532-6647.

animal models and later also in clinical studies in humans. SERVICE: For further information, please contact Dr. Christian Bär, baer.christian@mh-hannover.de , phone (0511) 532-2883. The original paper "AAV

After one year, the team can apply for a second round of funding. For further information , please contact Professor Dr. Dr. Axel Schambach, schambach.axel@mh-hannover.de , phone (0511) 532-5170.

German Cancer Aid is funding the study with 750,000 euros. SERVICE: For further information, please contact PD Dr. med. Matthias Jentschke, Jentschke.Matthias@mh-hannover.de, phone (0511) 532-6144.

Health Research and the Terry Fox Research Institute. SERVICE: For further information , please contact Professor Dr. Christian Kratz, telephone + 49 (511) 532-6712, kratz.christian@mh-hannover.de , or

sought. For more information about the study and conditions of participation, interested parties can contact zse-kontaktformular@mh-hannover.de .

is a huge gain for those affected," explains Professor Duncker. SERVICE: For more information , contact Professor Dr Roland Merten, Clinic for Radiotherapy and Special Oncology, merten.roland@mh-hannover

consultation helps with the personal decision," says Dr Wolters. SERVICE: For more information, contact Dr Mathias Wolters, wolters.mathias@mh-hannover.de